Tuberculosis in Household Contacts of Infectious Cases in Kampala, Uganda

American Journal of Epidemiology

Volumn 158, Issue 9, 2003, Pages 887-898

  Guwatudde, D ^a   Nakakeeto, M ^b   Jones Lopez, E C ^c,d   Maganda, A ^c   Chiunda, A ^c   Mugerwa, R D ^a   Eliner, J J ^c,d   Bukenya, G ^c   Whalen, Christopher C ^c  

^a MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^b MULAGO HOSPITAL   (Uganda)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Cohort studies; Disease transmission; Risk; Risk factors; Tuberculosis

Indexed keywords

DISEASE PREVALENCE; HEALTH RISK; RISK FACTOR; TUBERCULOSIS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; HOST; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SUPERINFECTION; TUBERCULOSIS; UGANDA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FAMILY HEALTH; FEMALE; HIV SEROPOSITIVITY; HUMANS; INFANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY; UGANDA;

UGANDA;

EID: 0142157171     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg227     Document Type: Article

References (46)

1. McPhedran FM, Opie EL. The spread of tuberculosis in families. Am J Hyg 1935;22:565-643.
2. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 1969;99:109-11.
3. Shaw JB, Wynn-Williams N. Infectivity of pulmonary tuberculosis in relation to sputum status. Am Rev Tuberc 1954;69:724-32.
4. Rose CE, Zerbe GO, Lantz SO, et al. Establishing priority during investigation of tuberculosis contacts. Am Rev Respir Dis 1979;119:603-9.
5. Fluffer RR, Zeidberg LD, Dillon A, et al. Tuberculosis attack and death rates of household associates. Am Rev Tuberc 1952;65:111-27.
6. Brailey M. A study of tuberculous infection and mortality in the children of tuberculous households. Am J Hyg 1940;31:1-43.
7. Kamat SR, Dawson JJY, Devadata S, et al. A controlled trial of the influence of segregation of tuberculosis patients for one-year on the attack rate of tuberculosis in a 5-year period in close family contacts in South India. Bull World Health Organ 1966;34:517-32.
8. Rosenthal SR, Loewinsohn E, Graham ML, et al. BCG vaccination in tuberculous households. Am Rev Respir Dis 1961;84:690-704.
9. Rosenthal SR, Loewinsohn E, Graham ML, et al. BCG vaccination against tuberculosis in Chicago. Pediatrics 1961;28:622-41.
10. Egsmose T, Ang'awa JOW, Poti SJ. The use of isoniazid among household contacts of open cases of pulmonary tuberculosis. Bull World Health Organ 1965;33:419-33.
11. Ferebee SH, Mount FW. Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts. Am Rev Respir Dis 1962;85:490-521.
12. Elliott AM, Hayes RJ, Haleiindi B, et al. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS 1993;7:981-7.
13. Nunn PP, Mungai M, Nyamwaya J, et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tuber Lung Dis 1994;75:25-32.
14. Klausner JD, Ryder R, Baende E, et al. Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type-1 seropositive patients with active pulmonary tuberculosis in Kinshasa, Zaire. J Infect Dis 1993;168:106-11.
15. Cruciani M, Malena M, Bosco O, et al. The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis. Clin Infect Dis 2001;33:1922-30.
16. Chapman JS, Dyerly MD. Social and other factors in intrafamilial transmission of tuberculosis. Am Rev Respir Dis 1964;90:48-60.
17. Rubel AJ, Garro LC. Social and cultural factors in the successful control of tuberculosis. Public Health Rep 1992;107:626-36.
18. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and the Centers for Disease Control and Prevention. Am J Respir Crit Care Med 1994;149:1359-74.
19. Sullivan KM, Gorstein J. ANTHRO software for calculating anthropometry. Version 1.02, Y2K compliant. Atlanta, GA: Centers for Disease Control and Prevention, 1999.
20. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
21. Dunlap NE, Bass JB, Fujiwara P, et al. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95.
22. Falk A, O'Connor JB, Pratt C. Classification of pulmonary tuberculosis. In: Diagnostic standards and classification of tuberculosis. New York, NY: National Tuberculosis and Respiratory Disease Association, 1969:68-76.
23. International Union against Tuberculosis and Lung Disease. Technical guide for sputum examination for tuberculosis by direct microscopy. Bull Int Union Tuberc Lung Dis 1986;61:1-16.
24. Whalen CC, Johnson JL, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997;337:801-8.
25. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60. Erratum in: Biometrics 1989;45:347.
26. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049-60. Erratum in: Biometrics 1989;45:347.
27. Starke JR. Diagnosis of tuberculosis in children. Pediatr Infect Dis J 2000;19:1095-6.
28. Eamranond P, Jaramillo E. Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis 2001;5:594-603.
29. Loudon RG, Williamson J, Johnson JM. An analysis of 3,485 tuberculosis contacts in the city of Edinburgh during 1954-1955. Am Rev Tuberc 1958;77:623-43.
30. Dow DJ, Lloyd WE. The incidence of tuberculous infection and its relation to contagion in children under 15. Br Med J 1931;2:183-6.
31. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Adv Tuberc Res 1970;17:28-106.
32. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974;99:131-8.
33. Edwards LD, Livesay VT, Aquaviva FA, et al. Height, weight, tuberculous infection, tuberculous disease. Arch Environ Health 1971;22:106-12.
34. Colditz GA, Brewer TF, Berkey CS, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. JAMA 1994;271:698-702.
35. O'Brien RJ, Perriens JH. Preventive therapy for tuberculosis in HIV infection: the promise and the reality. AIDS 1995;9:665-73.
36. Bellamy RJ, Hill AV. Host genetic susceptibility to human tuberculosis. Novartis Found Symp 1998;217:3-13.
37. Comstock G. Epidemiology of tuberculosis. Am Rev Respir Dis 1982;125:8-15.
38. Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. N Engl J Med 1992;326:231-5.
39. Espinal MA, Perez EN, Baez J, et al. Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet 2000;355:275-80.
40. Rodrigues LA, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8.
41. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000;49:1-51.
42. Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 1965;92:687-703.
43. MacMahon B, Pugh TF, Ipsen J. Epidemiologic concepts of cause. Epidemiologic methods. Boston, MA: Little, Brown and Company, 1960:11-22.
44. Jaramillo E. Encompassing treatment with prevention: the path for a lasting control of tuberculosis. Soc Sci Med 1999;49:393-404.
45. Lienhardt C. From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol Rev 2001;23:288-301.
46. van Rie A, Warren R, Richardson M, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;341:1174-9.